Beneficient (BENF) AI Stock Analysis

• Market Cap: $2.59M
• Dividend Yield: N/A
• Average Volume (3M): 1.76M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.68
• Revenue Growth: 78.84%
• EPS Growth: 97.65%
• Country: US
• Employees: 80
• Sector: Financial
• Sector Strength: 73
• Industry: Asset Management
• EPS (TTM): -1.32
• Shares Outstanding: 8,432,698
• 10 Day Avg. Volume: 555,060
• 30 Day Avg. Volume: 1,764,365
• PEG Ratio: 0.26
• Price to Book (P/B): 1.08
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -21.39
• Enterprise Value/Market Cap: 818.50
• Enterprise Value/Revenue: -20.96
• Enterprise Value/Gross Profit: 621.83
• Enterprise Value/Ebitda: -1.06
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 34 Underperform
• Price Target: ―

Beneficient's overall stock score reflects significant financial distress, with operational losses and solvency issues being the most critical factors. While there are positive developments in earnings and corporate events, they are overshadowed by weak technical indicators and an unfavorable valuation.

Beneficient Business Overview & Revenue Model

Company Description

Beneficient (BENF) is a financial services company that operates within the alternative asset management sector. The company specializes in providing liquidity solutions for investors in alternative assets, such as private equity, real estate, and other private market investments. Beneficient aims to offer a streamlined and efficient process for individuals and institutions seeking to access liquidity from their illiquid holdings.

How the Company Makes Money

Beneficient makes money by facilitating liquidity transactions for owners of alternative assets. The company charges fees for its services, which may include transaction fees, management fees, or advisory fees, depending on the nature of the transaction and the specific services provided. Beneficient's revenue model is supported by partnerships with financial institutions and investors seeking to optimize their portfolios by monetizing illiquid assets. The company may also earn income from structuring and managing bespoke liquidity solutions tailored to the needs of its clients.

Beneficient Financial Statement Overview

Summary

Beneficient's financial performance is poor due to negative net income, negative stockholders' equity, and negative cash flows, indicating significant operational losses, solvency issues, and liquidity challenges.

Income Statement

Beneficient's income statement shows significant challenges, with negative net income and EBIT across the periods, indicating operational losses. The TTM data shows a net profit margin of -336.99%, reflecting severe profitability issues. Despite a positive EBITDA margin of 14.38% in the TTM, the overall financial trajectory is concerning, with volatile revenue and negative growth rates.

Balance Sheet

The balance sheet reveals a negative stockholders' equity in the TTM period, suggesting potential solvency issues. The debt-to-equity ratio cannot be calculated due to negative equity, highlighting financial instability. The equity ratio is also negative, reflecting a worrisome financial position with high liabilities compared to assets.

Cash Flow

Cash flow statements indicate negative operating and free cash flows across periods, suggesting liquidity challenges. The TTM period's operating cash flow to net income ratio is not meaningful due to negative figures, and free cash flow growth is negative, showing a lack of cash generation capability.

Breakdown
TTM	Mar 2024	Mar 2023	Dec 2020	Dec 2019	Dec 2018
Income Statement		Total Revenue
16.25M	5.83M	-105.40M	101.98M	60.29M	79.47M
	Gross Profit
3.41M	-89.30M	-150.93M	81.20M	60.29M	75.80M
	EBIT
-65.22M	-2.74B	-253.17M	-47.41M	-135.38M	41.44M
	EBITDA
23.38M	-2.74B	-234.09M	-13.81M	-135.05M	41.68M
	Net Income Common Stockholders
-547.80M	-2.66B	-130.98M	-58.04M	-334.04M	-5.01M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
4.48M	7.98M	8.73M	12.49M	17.55M	3.54M
	Total Assets
368.79M	368.50M	2.91B	2.82B	2.68B	2.08B
	Total Debt
124.05M	2.20M	52.13M	180.08M	321.80M	378.12M
	Net Debt
119.57M	-5.78M	43.40M	167.59M	304.25M	374.58M
	Total Liabilities
256.45M	3.00K	1.02B	282.84M	441.08M	690.86M
	Stockholders Equity
-165.30M	368.50M	1.93B	2.53B	563.97M	320.46M
Cash Flow		Free Cash Flow
-51.86M	-59.98M	-97.19M	-57.23M	-54.17M	17.44M
	Operating Cash Flow
-50.12M	-58.22M	-95.12M	-54.01M	-51.19M	17.81M
	Investing Cash Flow
29.48M	44.06M	63.02M	-5.98M	70.44M	141.54M
	Financing Cash Flow
23.02M	12.59M	-34.46M	43.86M	-5.24M	-156.36M

Beneficient Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.30
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BENF, the sentiment is Negative. The current price of 0.3 is below the 20-day moving average (MA) of 0.33, below the 50-day MA of 0.31, and below the 200-day MA of 0.75, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 45.91 is Neutral, neither overbought nor oversold. The STOCH value of 17.06 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BENF.

Beneficient Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	64 Neutral	$12.77B	9.71	7.85%	78.05%	12.07%	-7.97%
TURN	52 Neutral	$39.40M	―	-8.01%	―	38.38%	71.72%
LRFC	52 Neutral	$44.35M	―	-8.58%	8.62%	678.57%	98.81%
BCG	46 Neutral	$34.87M	―	-11.19%	―	-13.79%	62.04%
CWD	45 Neutral	$4.57M	―	-5013.15%	―	-57.33%	-27.24%
PWM	42 Neutral	$11.86M	―		―	―	―
BENF	34 Underperform	$2.59M	―	-538.85%	―	78.84%	97.65%

Beneficient Corporate Events

Beneficient Completes Major Capital Transaction April 2025

On April 21, 2025, Beneficient completed a primary capital transaction involving a limited partner interest in an investment fund valued at $233,333. The transaction involved the issuance of Series B-7 Resettable Convertible Preferred Stock, convertible into Class A Common Stock, enhancing the collateral for Beneficient’s ExAlt loan portfolio. This marks Beneficient’s second GP Primary transaction of the fiscal year, reflecting its strategic focus on liquidity and primary capital solutions. The transaction is expected to increase the company’s tangible book value and aligns with its growth objectives, aiming to meet the substantial demand for primary commitments in the alternative asset market.

Spark’s Take on BENF Stock

According to Spark, TipRanks’ AI Analyst, BENF is a Underperform.

Beneficient’s overall stock score is low, primarily due to weak financial performance characterized by operational losses, solvency issues, and negative cash flow trends. Despite some positive developments in earnings and corporate events, the technical indicators and valuation remain unfavorable.

To see Spark’s full report on BENF stock, click here.

Beneficient Secures $9.6M in Primary Capital Transaction

On April 4, 2025, Beneficient closed a $9.6 million primary capital transaction with Pulse Pioneer Fund, LP, marking its first GP Primary transaction of the fiscal year. This transaction, involving the issuance of Series B-6 Resettable Convertible Preferred Stock, is expected to enhance the collateral for Beneficient’s ExAlt loan portfolio by approximately $9.6 million. The company believes this move will drive shareholder value and support its strategic vision and growth objectives, as it continues to address the significant demand for primary commitments in the alternative asset market.

Beneficient Settles GWG Litigation with Binding Agreement

On March 10, 2025, Beneficient announced a binding agreement to settle all claims in the GWG Litigation, which involved lawsuits in federal and bankruptcy courts in Texas against the company and its directors. The settlement, pending court approval, resolves claims without admission of fault and will be funded by insurance. This move aims to eliminate litigation costs and allow the company to focus on its business strategy, although other related claims remain outstanding.